Keywords
chronic diseases
elderly
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the relationship between polypharmacy and chronic diseases in individuals over 64 years of age. Methods: To analyze individuals over 64 years old, through pre-existing forms in a higher education institution, 146 forms corresponding to the research objectives were chosen. Results: 480 medical records were reviewed, 146 of which fit the eligibility of the research, that is, elderly people over 64 years old, most of the sample being female (64.4%). This analysis was performed by extracting data from medical records between 2015 and 2020, since the Polyclinic did not remain open for consultations during the pandemic period. The mean age was 71.4 years with a standard deviation of 6.6. Of the 146 selected, 124 (84.9%) had chronic diseases, 76 (52%) were on polypharmacy, of which 68 (89.4%) were patients with chronic diseases, and among the 70 (48%) who were not on polypharmacy, 56 (80%) patients had chronic diseases. Conclusion: The relationship between the use of polypharmacy and chronic diseases is within the pattern found. The prevalence of women using polypharmacy was similar to findings in other selected studies. All those selected had high blood pressure, diabetes mellitus, obesity and/or smoking as their main diseases.
References
ABREU SSS, et al. Prevalência de Doenças Crônicas não Transmissíveis em Idosos de uma Cidade do Interior da Bahia. Id on Line Revista Multidisciplinar e de Psicologia, 2017; 11(38): 65-662.
ARAÚJO LU, et al. Segurança do paciente e polimedicação na Atenção Primária à Saúde: pesquisa transversal em pacientes com doenças crônicas. Revista Latino-Americana de Enfermagem, 2019; 27(e3181): e3217.
AZEVEDO ALS, et al. Doenças crônicas e qualidade de vida na atenção primária à saúde. Cadernos de Saúde Pública, 2013; 29(9): 1774-1782.
BOJUWOYE AO, et al. Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa. Journal of Pharmaceutical Policy and Practice, 2022; 15(1).
CHEN Z e BUONANNO A. Geriatric Polypharmacy: Two Physicians' Personal Perspectives. Clinics in geriatric medicine, 2017; 33(2): 283–288.
CHOU J, et al. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications. Journal of gerontological nursing, 2019; 45(1): 9–15.
CONSTANTINO JL, et al. Polypharmacy, inappropriate medication use and associated factors among brazilian older adults. Cadernos Saúde Coletiva [Internet], 2020; 28(3): 400–8.
FEDOCE AG, et al. Análise do perfil medicamentoso de idosos polimedicados no município de Sinop - MT. Revista Eletrônica Acervo Saúde, 2021; 13(2): e5863.
GRZELCZAK MT, et al. O diabetes sob o aspecto epidemiológico e políticas de promoção de saúde por meio da atividade física. Rev cientifica UMC, Mogi das Cruzes, 2017; 2(2).
HALLI-TIERNEY AD, et al. Polypharmacy: Evaluating Risks and Deprescribing. American family physician, 2019; 100(1): 32–38.
ISER BPM, et al. Prevalência de diabetes autorreferido no Brasil: resultados da Pesquisa Nacional de Saúde 2013. Epidemiologia e Serviços de Saúde, 2015; 24(2): 305–14.
LIBERATTI A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med, 2009; 6(7): e1000100.
LUTZ BH, et al. Potentially inappropriate medications among older adults in Pelotas, Southern Brazil. Revista de Saúde Pública, 2017; 51(0).
MALTA DC, et al. Tendência temporal dos indicadores de excesso de peso em adultos nas capitais brasileiras, 2006-2013. Ciência & Saúde Coletiva, 2016; 21(4): 1061–9.
MAUÉ CR, et al. Análise do uso de medicamentos em idosos. Revista Eletrônica Acervo Saúde, 2019; (34): e1356.
MENDES SBE, et al. Prevalência de uso de medicamentos em população rural brasileira. Cadernos Saúde Coletiva [Internet], 2022; 30(3):361–73.
McQUADE BM e CAMPBELL A. Drug Prescribing: Polypharmacy and Deprescribing. FP essentials, 2021; 508: 33–40.
MORIN L, et al. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clinical Epidemiology, 2018; 10: 289–98.
NASCIMENTO RCRM, et al. Polifarmácia: uma realidade na atenção primária do Sistema Único de Saúde. Revista de Saúde Pública, 2017; 51 Supl 2: 19s.
OLIVEIRA PC, et al. Prevalência e Fatores Associados à Polifarmácia em Idosos Atendidos na Atenção Primária à Saúde em Belo Horizonte-MG, Brasil. Ciência & Saúde Coletiva, 2021; 26(4): 1553-1564.
PEREIRA KG, et al. Polifarmácia em idosos: um estudo de base populacional. Revista Brasileira de Epidemiologia, 2017; 20(02): 335-344.
PINTO ECP, et al. O uso de fármacos anticolinérgicos e fatores associados em adultos de meia-idade e idosos. Ciência & Saúde Coletiva, 2022; 27(6): 2279–90.
RAMOS LR, et al. Polypharmacy and Polymorbidity in Older Adults in Brazil: a public health challenge. Revista de Saúde Pública, 2016; 50(suppl 2): 9s.
SECOLI SR. Polifarmácia: interações e reações adversas no uso de medicamentos por idosos. Revista brasileira de enfermagem, 2010; 63(1): 136-140.
SILVA IR, et al. Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil. Revista Brasileira de Epidemiologia, 2020; 23.
SILVEIRA EA, et al. Polypharmacy, chronic diseases and nutritional markers in community-dwelling older. Revista Brasileira de epidemiologia, 2014; 17(4): 818-829.
SOUSA CR, et al. Factors associated with vulnerability and fragility in the elderly: a cross-sectional study. Revista Brasileira de Enfermagem [online], 2022; 75: 02.
SOUZA AM, et al. Vulnerabilidade clínico-funcional de idosos em polifarmácia segundo os critérios de Beers. Revista Eletrônica Acervo Saúde, 2022; 15(11): e11395.
WORLD HEALTH ORGANIZATION. Medication Without Harm – Global Patient Safety Challenge on Medication Safety. Geneva: World Health Organization, 2017. Disponível em: https://www.who.int/initiatives/medication-without-harm. Acessado em: 26 de junho de 2021.